Nuclear medicine imaging to guide antibiotic therapy: an expert review
British Journal of Radiology · 01.06.2026 · 99 (1182) · 1024-1035
DOI: 10.1093/bjr/tqag068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Radiology, online erschienen am 26.03.2026. Verfasst von Domenico Albano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, University of Brescia, Brescia 25123, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacterial Infections, Nuclear Medicine, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bacterial infections and multidrug resistance remain a major global threat. New clinical tools are, therefore, urgently needed to identify bacterial infections and monitor response to antibiotics. Nuclear medicine imaging affords unique opportunities to target and identify bacterial infections, enabling spatial characterization as well as noninvasive, temporal monitoring of the natural course of the disease and response to therapy. In this expert review, we present an overview of the role of [18F]-FDG PET/CT and WBC scintigraphy with or without SPECT/CT in predicting treatment response to antibiotics and guide their interruption. A decrease in the [18F]FDG uptake or a change of uptake patterns could be potentially used to assess the results of antibiotic therapy in patients with different infectious diseases, despite robust evidence lacking. Concerning WBC scan, their high specificity to target and accumulation over time in infected areas is crucial for the differential diagnosis between infections and sterile inflammation, thus being useful also for therapy follow-up. However, specificity can be reduced in patients with ongoing antibiotics and little is known about the best time window to perform scintigraphy. Finally, we analyzed the potential usefulness of most promising radiolabelled bacterial tracers as potential alternative to FDG and WBC for therapy follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine, University of Brescia, Brescia 25123, Italy.
- Nuclear Medicine Department, ASST Spedali Civili di Brescia, Brescia, 25123, Italy.
- Nuclear Medicine Unit, Department Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, Rome 00189, Italy.
- Division of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, 6500, Switzerland.
- Faculty of Biology and Medicine, University of Lausanne, Lausanne 1015, Switzerland.
- Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano 6900, Switzerland.
ORCID-Profile: Domenico Albano, Chiara Lauri, Alberto Signore, Giorgio Treglia
Zitieren
APA
Albano, D., Lauri, C., Signore, A., & Treglia, G. (2026). Nuclear medicine imaging to guide antibiotic therapy: an expert review. British Journal of Radiology, 99(1182), 1024-1035. https://doi.org/10.1093/bjr/tqag068
Vancouver
Albano D, Lauri C, Signore A, Treglia G. Nuclear medicine imaging to guide antibiotic therapy: an expert review. British Journal of Radiology. 2026;99(1182):1024-1035. doi:10.1093/bjr/tqag068
BibTeX
@article{Albano2026,
author = {Albano, Domenico and Lauri, Chiara and Signore, Alberto and Treglia, Giorgio},
title = {Nuclear medicine imaging to guide antibiotic therapy: an expert review},
journal = {British Journal of Radiology},
year = {2026},
volume = {99},
number = {1182},
pages = {1024--1035},
doi = {10.1093/bjr/tqag068}
}
EUVIMED